ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08535
-0,01%
Bitcoin
69.784,07
-0,49%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) News

ABSI

AbSci (ABSI)

AbSci Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ABSI
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202413h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABSIAbSci Corporation
14/05/202413h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
14/05/202413h30GlobeNewswire Inc.Absci Reports Business Updates and First Quarter 2024 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
16/04/202414h00GlobeNewswire Inc.Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024NASDAQ:ABSIAbSci Corporation
28/03/202421h05GlobeNewswire Inc.Absci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
21/03/202412h30GlobeNewswire Inc.Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
01/03/202422h01GlobeNewswire Inc.Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ABSIAbSci Corporation
28/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
28/02/202414h34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
28/02/202404h20GlobeNewswire Inc.Absci Announces Pricing of Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
27/02/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
27/02/202422h40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
27/02/202422h01GlobeNewswire Inc.Absci Announces Proposed Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
21/02/202413h30GlobeNewswire Inc.Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AINASDAQ:ABSIAbSci Corporation
20/02/202414h00GlobeNewswire Inc.Absci to Participate in Upcoming Investor ConferencesNASDAQ:ABSIAbSci Corporation
14/02/202400h16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABSIAbSci Corporation
06/02/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202401h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202401h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
10/01/202413h30GlobeNewswire Inc.Absci Appoints Professor Sir Mene Pangalos to its Board of DirectorsNASDAQ:ABSIAbSci Corporation
08/01/202413h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
08/01/202413h00GlobeNewswire Inc.Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
04/01/202422h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
04/01/202422h57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
03/01/202414h00GlobeNewswire Inc.Absci to Participate in the 26th Annual Needham Growth ConferenceNASDAQ:ABSIAbSci Corporation
28/12/202314h00GlobeNewswire Inc.Absci to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
20/12/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
20/12/202313h30GlobeNewswire Inc.Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineNASDAQ:ABSIAbSci Corporation
07/12/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
 Showing the most relevant articles for your search:NASDAQ:ABSI

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
FX
EURJPY
Euro vs Yen
AMEX
SPY
SPDR S&P 500
FX
EURGBP
Euro vs Sterling
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
TG
TUI1
Tui
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
COIN
SOLUSD
Solana
TG
D7G
Nel ASA
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten